AIM AIM ImmunoTech Inc.

BEARISH Impact: 6/10 8-K
Horizon days Filed Apr 10, 2026 Processed 2mo ago SEC 0001493152-26-016179
8-K Item 1.01 + 5.02 (likely routine officer/director compensation agreement)
Latest settled — T+20d ⚠ clustered
AIM ▼ -41.51% at T+20d
SHORT call ✓ call won +41.51% · α vs SPY +49.24% · entry $0.5300 → $0.3100
Next anchor: T+60d in 27d
Currently $0.4030 · +23.96% from $0.5300 entry (call sign-flipped)
Entry anchored
Apr 10, 03:59 PM ET
via Databento tick
T+1d
+9.43%
call -9.43% · α -8.22%
$0.5800
settled 8w ago
T+5d
-7.55%
call +7.55% · α +10.84%
$0.4900
settled 8w ago
T+20d
-41.51%
call +41.51% · α +49.24%
$0.3100
settled 5w ago
T+60d
call — · α —
in 27d

Price Chart

Loading chart...

Executive Summary

AIM ImmunoTech Inc. amended its equity distribution agreement with Maxim Group LLC to remove the $3 million cap on its at-the-market (ATM) offering, effectively expanding its shelf registration to $3.41 million. This follows a recent capital raise under the same shelf registration.

Actionable Insight

Traders should monitor for immediate stock sales under the expanded ATM program, which could lead to significant dilution for existing shareholders given the company's small market cap. The timing of this expansion immediately after a prior raise suggests ongoing capital needs.

Key Facts

  • Amended Equity Distribution Agreement to remove $3 million cap on ATM offering
  • Simultaneously filed a prospectus supplement to increase the offering size
  • Follows a recent $1.12 million capital raise under the same shelf
  • Company is an emerging growth company with a $4M market cap

Financial Impact

Undisclosed amount raised under expanded shelf, previously sold $2.29 million under $3 million cap

dilutiondebt

Risk Factors

  • Dilution of existing shareholders
  • Downward pressure on stock price from potential share sales
  • Ongoing capital needs despite recent fundraising

Market Snapshot

Exchange
NYSE
Sector
Biological Products, (No Diagnostic Substances)

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-016179
Exhibit: ex3-1.htm0001493152-26-016179
Exhibit: ex5-1.htm0001493152-26-016179
Document: 0001493152-26-016179-index-headers.html0001493152-26-016179
Document: 0001493152-26-016179-index.html0001493152-26-016179
Document: 0001493152-26-016179.txt0001493152-26-016179
17 reports for AIM
Performance horizon
50% Hit rate 4 of 8 directional calls best @ T+20▲ +46.55%Apr 13, 2026
Filters
Rows
Reports for AIM — sortable, filterable
Type Now
Jun 8, 2026
1d ago
Press Release
BULLISH ★ 5/10
$0.4589 awaiting T+1awaiting T+1$0.4030 (−12.18%)
Jun 4, 2026
5d ago
8-K
NEUTRAL ★ 3/10
$0.5900 $0.5200▼ −11.86%▼ −9.27%$0.4030 (−31.69%)
Jun 1, 2026
8d ago
Press Release
NEUTRAL ★ 4/10
$0.9000 $0.8300▼ −7.78%▼ −7.92%$0.4030 (−55.22%)
May 21, 2026
19d ago
8-K
BEARISH ★ 8/10
$0.2400 $0.2400· 0.00%▲ +0.45%$0.4030 (−67.92%)
May 21, 2026
19d ago
424B5
BEARISH ★ 7/10
$0.2400 $0.2400· 0.00%▲ +0.45%$0.4030 (−67.92%)
May 20, 2026
20d ago
Press Release
BEARISH ★ 7/10
$0.2500 $0.2400▲ +4.00%▲ +4.19%$0.4030 (−61.20%)
May 19, 2026
21d ago
424B5
MIXED ★ 5/10
$0.2500 $0.2400▼ −4.00%▼ −4.19%$0.4030 (+61.20%)
May 19, 2026
21d ago
8-K
MIXED ★ 6/10
$0.4100 $0.2500▼ −39.02%▼ −40.06%$0.4030 (−1.71%)
May 14, 2026
26d ago
8-K
BULLISH ★ 6/10
$0.2600 $0.2500▼ −3.85%▼ −2.62%$0.4030 (+55.00%)
May 14, 2026
26d ago
Press Release
NEUTRAL ★ 4/10
$0.2600 $0.2500▼ −3.85%▼ −2.62%$0.4030 (+55.00%)
Showing 10 of 17

US Market Status

Market Closed — Opens Thu (11h)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access